skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Tc-99m Labeled carrier for imaging

Patent ·
OSTI ID:864878
 [1]
  1. Santa Monica, CA
+ Show Author Affiliations

Novel radionuclide imaging agents, having particular application for lymphangiography are provided by non-covalently binding Tc-99m to a pharmaceutically acceptable cross-linked polysaccharide. Upon injection of the Tc-99m labeled polysaccharide into the blood stream, optimum contrast can be obtained within one hour.

Research Organization:
Univ. of California (United States)
DOE Contract Number:
AM03-76SF00012
Assignee:
Regents of University of California (Berkeley, CA)
Patent Number(s):
US 4431626
OSTI ID:
864878
Country of Publication:
United States
Language:
English

Similar Records

TC-99M labeled carrier for imaging
Patent · Tue Feb 14 00:00:00 EST 1984 · OSTI ID:864878
A novel approach to infection imaging using a synthetic Tc-99m-labeled leukotactic peptide
Journal Article · Wed May 01 00:00:00 EDT 1996 · Journal of Nuclear Medicine · OSTI ID:864878
Labeling of red blood cells with Tc-99m after oral administration of SnCl/sub 2/. Concise communication. [In vivo studies in rats and man]
Journal Article · Wed Aug 01 00:00:00 EDT 1979 · J. Nucl. Med.; (United States) · OSTI ID:864878
+1 more

Related Subjects

tc-99m
labeled
carrier
imaging
novel
radionuclide
agents
particular
application
lymphangiography
provided
non-covalently
binding
pharmaceutically
acceptable
cross-linked
polysaccharide
injection
blood
stream
optimum
contrast
obtained
hour
imaging agents
particular application
pharmaceutically acceptable
blood stream
imaging agent
/424/